Oscotec Inc. (KOSDAQ:039200)
South Korea
· Delayed Price · Currency is KRW 31,150
+1,100 (3.66%)
Apr 1, 2025, 3:30 PM KST
Oscotec Revenue
In the year 2024, Oscotec had annual revenue of 34.01B KRW with 586.89% growth. Oscotec had revenue of 2.34B in the quarter ending December 31, 2024, with 663.97% growth.
Revenue
34.01B
Revenue Growth
+586.89%
P/S Ratio
34.91
Revenue / Employee
666.82M
Employees
51
Market Cap
1,191.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.01B | 29.06B | 586.89% |
| Dec 31, 2023 | 4.95B | -111.45M | -2.20% |
| Dec 31, 2022 | 5.06B | 1.16B | 29.71% |
| Dec 31, 2021 | 3.90B | -39.57B | -91.02% |
| Dec 31, 2020 | 43.47B | 39.10B | 895.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |